Nutritional status in patients with diabetes and chronic kidney disease: A prospective study

American Journal of Clinical Nutrition

Volumn 85, Issue 1, 2007, Pages 96-101

  Raffaitin, Christelle ^a,b   Lasseur, Catherine ^a   Chauveau, Philippe ^a   Barthe, Nicole ^a   Gin, Henri ^a   Combe, Christian ^a   Rigalleau, Vincent ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Service de Diabétologie Nutrition   (France)

Author keywords

Body composition; Chronic kidney disease; Diabetes mellitus; Nutritional status; Prospective study; Resting energy expenditure

Indexed keywords

ALBUMIN; CHROMIUM 51; EDETIC ACID; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; WATER;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENERGY EXPENDITURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE INTAKE; HEALTH PROGRAM; HEMODIALYSIS; HUMAN; MALE; NUTRITIONAL STATUS; PROTEIN INTAKE; TREATMENT OUTCOME;

EID: 33846065253     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.1.96     Document Type: Article

References (59)

1. Mitch WE. Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr 1998;67:359-66.
2. Coles GA. Body composition in chronic renal failure. Q J Med 1972;41:25-47.
3. Aparicio M, Cano N, Chauveau P, et al. Nutritional status of haemodialysis patients: a French national cooperative study. French Study Group for Nutrition in Dialysis. Nephrol Dial Transplant 1999;14:1679-86.
4. Combe C, Chauveau P, Laville M, et al. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis 2001;37:S81-8.
5. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005;67:1684-91.
6. Chantrel F, Enache I, Bouiller M, et al. Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant 1999;14:129-36.
7. Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-13.
8. Jungers P, Zingraff J, Page B, Albouze G, Hannedouche T, Man NK. Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int 1993;41(suppl):S170-3.
9. La prise en charge des Diabétiques Urémiques-Régles de bonnes pratiques cliniques. Rapport des experts de l'ALFEDIAM et de la Société de Néphrologie. (Management of uremic diabetics: standards for good clinical practice. ALFEDIAM and Society of Nephrology expert meeting.) Diabetes Metab 1999;25(suppl):1-72 (in French).
10. Cano NJ, Roth H, Aparicio M, et al. Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int 2002;62:593-601.
11. Avesani CM, Cuppari L, Silva AC, et al. Resting energy expenditure in pre-dialysis diabetic patients. Nephrol Dial Transplant 2001;16:556-65.
12. Charlton M, Nair KS. Protein metabolism in insulin-dependant diabetes mellitus. J Nutr 1998;128(suppl):323S-7S.
13. Pupim LB, Flakoll PJ, Majchrzak KM, Aftab Guy DL, Stenvinkel P, Ikizler TA. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 2005;68:1857-65.
14. Gretz N, Lasserre J, Strauch M. Caloric supplements for patients on low-protein diets? Nephron 1988;50:129-32.
15. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93.
16. Groupe de travail de l'ANAES, traitement médicamenteux du diabète de type 2 à l'exclusion des complications. Recommandations: texte long, argumentaire. (Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES.) Diabetes Metab 1999;25(suppl):1-64 (in French).
17. Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care 1998;26:S23-31.
18. Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabetes Care 2003;26(suppl):S80-2.
19. Groupe de travail de l'ANAES, recommandations pour la pratique clinique, "moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique de l'adulte." (Therapeutic tools to slow adult chronic kidney failure progression. Recommendations of ANAES.) Agence Nationale d'Accréditation des Etablissements de Santé. Internet: http://www.anaes.fr (accessed 15 December 2005).
20. Detection and management of lipid disorders in diabetes. American Diabetes Association. Diabetes Care 1993;16:828-34.
21. National Kidney Foundation. Kidney disease outcome quality initiative. Clinical practice guidelines for nutrition in chronic renal failure. I. Adult guidelines. B. Advanced chronic renal failure without dialysis. Am J Kidney Dis 2000;35:S56-65.
22. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58-65.
23. Masud T, Manatunga A, Cotsonis G, Mitch WE. The precision of estimating protein intake of patients with chronic renal failure. Kidney Int 2002;62:1750-6.
24. Avesani CM, Kamimura MA, Draibe SA, Cuppari L. Is energy intake underestimated in nondialyzed chronic kidney disease patients? J Ren Nutr 2005;15:159-65.
25. Rigalleau V, Lasseur C, Perlemoine C, et al. Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? Diabetes Care 2005;28:838-43.
26. DuBois D, DuBois E. A formula to estimate the approximate surface area if height and weight are known. Ann Intern Med 1916;17:863-71.
27. Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual energy X-ray absorptiometry (DXA). Clin Physiol 1991;11:331-41.
28. Boulier A, Fricker J, Thomasset AL, Apfelbaum M. Fat-free mass estimation by the two-electrode impedance method. Am J Clin Nutr 1990;52:581-5.
29. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988;37:287-301.
30. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int 2001;59:702-9.
31. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 1999;42:406-12.
32. Sinha A, Formica C, Tsalamandris C, et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med 1996;13:40-6.
33. Rigalleau V, Delafaye C, Baillet L, et al. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study. Diabetes Metab 1999;25:321-8.
34. Weyer C, Bogardus C, Pratley RE. Metabolic factors contributing to increased resting metabolic rate and decreased insulin-induced thermogenesis during the development of type 2 diabetes. Diabetes 1999;48:1607-14.
35. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 1984;27:13-6.
36. O'Sullivan AJ, Lawson JA, Chan M, Kelly JJ. Body composition and energy metabolism in chronic renal insufficiency. Am J Kidney Dis 2002;39:369-75.
37. Rigalleau V, Lasseur C, Pecheur S, et al. Resting energy expenditure in uremic, diabetic, and uremic diabetic subjects. J Diabet Compl 2004;18:237-41.
38. Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002;62:220-8.
39. Pijls LT, de Vries H, van Eijk JT, Donker AJ. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr 2002;56:1200-7.
40. Walser M. Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney Int 1993;44:1139-44.
41. Aparicio M, Chauveau P, De Precigout V, Bouchet JL, Lasseur C, Combe C. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 2000;11:708-16.
42. Gin H, Aparicio M, Potaux L, de Precigout V, Bouchet JL, Aubertin J. Low protein and low phosphorus diet in patients with chronic renal failure: influence on glucose tolerance and tissue insulin sensitivity. Metabolism 1987;36:1080-5.
43. Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest 2002;110:437-9.
44. Utaka S, Avesani CM, Draibe SA, Kamimura MA, Andreoni S, Cuppari L. Inflammation is associated with increased energy expenditure in patients with chronic kidney disease. Am J Clin Nutr 2005;82:801-5.
45. Ikizler TA, Pupim LB, Brouillette JR, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 2002;282:E107-16.
46. Pupim LB HO, Qureshi AR, Ikizler TA. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 2005;68:2368-74.
47. Don BR, Kaysen GA. Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol 2000;13:249-59.
48. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-8.
49. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-6.
50. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006;17:1453-9.
51. Rigalleau V, Lasseur C, Perlemoine C, et al. Cockroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism 2006;55:108-12.
52. Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant 2005;20:2394-401.
53. Evans M, Fryzek JP, Elinder CG, et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005;46:863-70.
54. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Factors predictive of nephropathy in DCCT type 1 diabetic patients with good or poor metabolic control. Diabet Med 2003;20:580-5.
55. Cusick M, Chew EY, Hoogwerf B, et al. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report no. 26. Kidney Int 2004;66:1173-9.
56. Babazono T, Hanai K, Suzuki K, et al. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia 2006;49:1387-93.
57. Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int 2003;63:1499-507.
58. Mulec H, Blohme G, Grande B, Bjorck S. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrol Dial Transplant 1998;13:651-5.
59. Fontsere N, Salinas I, Bonal J, et al. Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? Nephrol Dial Transplant 2006;21:2152-8. Epub 2006 May 15.